Abeer H. Elmaidomya,
Usama Ramadan Abdelmohsen*bc,
Faisal Alsenanid,
Hanan F. Alye,
Shams Gamal Eldin Shamse,
Eman A. Younise,
Kawkab A. Ahmedf,
Ahmed M. Sayedg,
Asmaa I. Owisah,
Naglaa Afifia and
Dalia El Amira
aDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
bDepartment of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt. E-mail: usama.ramadan@mu.edu.eg
cDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, 7 Universities Zone, New Minia 61111, Egypt
dDepartment of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia
eTherapeutic Chemistry Department, National Research Centre (NRC), El-Bouth St., P.O. 12622, Cairo, Egypt
fDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt
gDepartment of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef, 62513, Egypt
hDepartment of Pharmacognosy, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt
First published on 11th January 2024
Expression of concern for ‘The anti-Alzheimer potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches’ by Abeer H. Elmaidomy et al., RSC Adv., 2022, 12, 11769–11785, https://doi.org/10.1039/D2RA01340A.
Laura Fisher
4th January 2024
Executive Editor, RSC Advances
This journal is © The Royal Society of Chemistry 2024 |